COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Propofol Versus Ketamine for Moderate Procedural Sedation in the Emergency Department (ED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00997321
Recruitment Status : Completed
First Posted : October 19, 2009
Results First Posted : March 26, 2012
Last Update Posted : April 2, 2012
Information provided by (Responsible Party):
Hennepin Healthcare Research Institute

Brief Summary:
This study is a clinical trial of moderate sedation with propofol versus moderate sedation with ketamine for procedural sedation in the Emergency Department.

Condition or disease Intervention/treatment Phase
Sedation Drug: propofol Drug: Ketamine Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Propofol Versus Ketamine for Procedural Sedation During Painful Procedures in the Emergency Department
Study Start Date : July 2007
Actual Primary Completion Date : October 2009
Actual Study Completion Date : October 2009

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Propofol
propofol 1 milligram per kilogram intravenous bolus followed by 0.5 millligrams per kilogram as needed for mooderate procedural sedation
Drug: propofol
propofol 1 millgram per kilogram intravenous bolus followed by 0.5 milligrams per kilogram as needed for moderate procedural sedation

Active Comparator: Ketamine
ketamine 1 milligram per kilogram followed by 0.5 millgram per kilogram as needed for moderate procedural sedation
Drug: Ketamine
ketamine milligram per kilogram followed by 0.5 milligrams per kilogram as need for moderate procedural sedation

Primary Outcome Measures :
  1. Respiratory Depression (Sub-clinical and Clinical Signs) [ Time Frame: From one minute prior to start of the procedure until the patient has returned to baseline mental status after the conclusion of the sedation procedure up to 60 minutes) ]
    binary measure based on the occurrence of an oxygen saturation less than 93 at any time, a change in baseline end tidal co2 >10 or an absence on capnographic waveform

Secondary Outcome Measures :
  1. Time to Return of Baseline Mental Status [ Time Frame: from start of procedure until the return of baseline mental status up to 120 minutes ]
    time in seconds from the first dose of medication until the patient has regained baseline mental status

  2. Patient Reported Pain or Recall of the Procedure [ Time Frame: single measurement immediately after patient returns to baseline mental status after sedation procedure ]
    patient completed question after return to baseline mental status "did you feel pain during the procedure" and "do you remember any part of the procedure" answered by circling yes or no on a question sheet, positive if yes to either question

  3. Depth of Sedation [ Time Frame: single measurement during sedation procedure ]
    Observes assesment of alertness scale, 1-5 ordinal scale measuring level of awareness, one represents awake, 5 general anesthesia/unresponsive to pain

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients who require moderate procedural sedation with propofol in the ED

Exclusion Criteria:

  • age > 17 years
  • pregnant
  • intoxicated
  • cannot give informed consent
  • allergy to ketamine or propofol
  • patient will require deep procedural sedation
  • ASA physical status score > 2

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00997321

Layout table for location information
United States, Minnesota
Hennepin County Medical Center
Minneapolis, Minnesota, United States, 55415
Sponsors and Collaborators
Hennepin Healthcare Research Institute
Layout table for investigator information
Principal Investigator: James R Miner, MD Hennepin Healthcare Research Institute
Publications of Results:
Layout table for additonal information
Responsible Party: Hennepin Healthcare Research Institute Identifier: NCT00997321    
Other Study ID Numbers: MMRF062661
First Posted: October 19, 2009    Key Record Dates
Results First Posted: March 26, 2012
Last Update Posted: April 2, 2012
Last Verified: March 2012
Keywords provided by Hennepin Healthcare Research Institute:
procedural sedation
moderate procedural sedation in the ED
Additional relevant MeSH terms:
Layout table for MeSH terms
Disease Attributes
Pathologic Processes
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Sensory System Agents
Peripheral Nervous System Agents
Anesthetics, Dissociative
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action